Digital CMC Basecamp — Basel

Our first Digital CMC Basecamp in Basel focused on the digitalization of tech transfer workstreams with an emphasis on how data sitting in ELNs, LIMS, and other data sources can be contextualized and utilized for these activities. See how companies are thinking about these problems and the technologies and practices that are being deployed to reduce cycle times so that patients can access novel therapies sooner rather than later.

In the executive suites of most pharma and biotech companies, a key discussion taking place today is the need to significantly reduce the cycle times of drug development. One area of focus to achieve more immediate reductions in cycle time is the set of activities known as tech transfer. Traditionally a document-based process, but today digitalization presents an opportunity to significantly reduces times from the current 18-24 months to 3-6 months.

With 70%-80% of manufacturing data unstructured, the burden on users is high as time is wasted looking for information. And while AI can be a valuable tool, it will still require integrated knowledge that can be used to build process models supported by high-quality empirical data.

At Digital CMC Basecamp in Basel, we focused on digitalizing tech transfer workstreams, emphasizing how data from ELNs, LIMS, and other sources can be contextualized and used effectively. Watch our on-demand videos to discover how companies are addressing these challenges and the technologies and practices they’re adopting to shorten cycle times, helping patients access new therapies faster.